WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

NMPA Solicits Public Comments on Drug Contract Manufacturing Document In order to strengthen the supervision and management of pharmaceutical contract manufacture and promote the high-quality development of the pharmaceutical industry, the ...
(11/5/2024)

2025 Forecast: What Can AstraZeneca's China Pr... (12/30/2024)

Improving Access to Cardiovascular Care for 1.... (12/23/2024)

China's Position and Competitiveness in The G... (12/18/2024)

A Growing Phenomenon: The Rise of Biopharma Ne... (12/16/2024)

Leading Medical Apps by Monthly Active Users i... (12/12/2024)

The New Draft Administrative Measures For Mana... (12/10/2024)

How Wholly Foreign-Owned Hospitals Can Help Ch... (12/10/2024)

China Biopharma Tracker – November 2024 (Phar... (12/10/2024)

Big Pharma Doubles Down on China (The Wire Chi... (12/5/2024)

2025 Trends Buoying Boom Phase in APAC (Biospe... (12/5/2024)

Big Pharma's Bet on China Biotech Is a Rare Tr... (12/3/2024)

Asian Market Rattled by Trump Tariffs: Yang Re... (11/27/2024)

Cure Genetics Secures Series B Financing... (1/7/2025) Junshi Secures NMPA Approval for Toripal... (1/7/2025) Gene Vector Secures Strategic Financing (1/7/2025) Insilico Medicine Secures Over $100M in ... (1/7/2025) NHC Issues Guidelines for Clinical Use o... (1/6/2025) Solasia Pharma Partners with GenSci to B... (1/6/2025) I-Mab Reprioritizes Pipeline and Halts C... (1/6/2025) WuXi Bio Divests Irish Vaccine Facility ... (1/6/2025) GSK's Nucala Gains Expanded Approval in ... (1/6/2025) China Launches Action Plan to Tackle Dem... (1/6/2025) CDE Issues the List of Reference Formula... (1/6/2025) NMPA Withdraws Registration of All Bella... (1/6/2025) State Council Issues New Policy Document... (1/6/2025) Chinese Researchers Use AI to Accelerate... (1/6/2025) Recent Official and Executive Moves (1/3/2025) Platinum Life Receives Conditional Appro... (1/3/2025) Prime Gene Therapeutics Completes Over C... (1/3/2025) Gilead's Sunlenca (lenacapavir) Receives... (1/3/2025)

Review of China's Hospital Drug Market: Strong Competit... Chinese Generic Drug Market Expected to Rise at 10.70% ... China's Expanding Proton Therapy Market: Key Drivers NH DB6: Global and Chinese Consumer Healthcare Market:... SMEI: Chinese Terminal Drug Market Fell 1.9% in H1/2024...

Insilico Medicine Secures Over $100M in Equity Financin... Gene Vector Secures Strategic Financing Junshi Secures NMPA Approval for Toripalimab in 2nd-Lin... Cure Genetics Secures Series B Financing to Drive CGT I... WuXi Bio Divests Irish Vaccine Facility to Merck Amid P...

State Council Issues New Policy Document on Deepens Ref... NMPA Withdraws Registration of All Belladonna Sulfobenz... CDE Issues the List of Reference Formulations for GQCE ... China Punishes 40,000 in Medical Corruption Crackdown, ... NMPA Withdraws Registration for Belladonna Sulfabenzami...

China Launches Action Plan to Tackle Dementia amid Agin... NHC Issues Guidelines for Clinical Use of New Anticance... China Launches Mini-Programs to Boost Drug Price Transp... China Strengthens Oversight of Medical Insurance Funds ... China Prioritizes Mental Health with Nationwide Initiat...

Oxford Nanopore Sues Chinese Biotech Giant BGI Over All... Congress Debates Biosecure Act Amid Report Highlighting... China Targets AstraZeneca in BMI Fraud Probe over Tagri... AstraZeneca China President Under Investigation Amid Br... BeiGene Executive Under Investigation in China Amid Scr...

Implications of China's Growing Influence in Global Pha... FDA Issues Warning to Tianjin Darentang for Manufacturi... Shanghai Pharma Considers API Partnerships with Indian ... Aurobindo Challenges China in the Global Penicillin G M... India Mulls New PLI Scheme to Reduce Chinese API Depend...

Chinese Researchers Use AI to Accelerates Discovery of ... GSK's Nucala Gains Expanded Approval in China for CRSwN... Biocon Wins NMPA Approval for Tacrolimus Capsules in Ch... Astellas' Vyloy (zolbetuximab) Receives Marketing Appro... Gilead's Sunlenca (lenacapavir) Receives Marketing Appr...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Official and Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...